David H. Abramson

19.9k total citations · 1 hit paper
400 papers, 12.0k citations indexed

About

David H. Abramson is a scholar working on Ophthalmology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David H. Abramson has authored 400 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 354 papers in Ophthalmology, 124 papers in Oncology and 81 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David H. Abramson's work include Ocular Oncology and Treatments (330 papers), Cancer-related Molecular Pathways (75 papers) and Glioma Diagnosis and Treatment (69 papers). David H. Abramson is often cited by papers focused on Ocular Oncology and Treatments (330 papers), Cancer-related Molecular Pathways (75 papers) and Glioma Diagnosis and Treatment (69 papers). David H. Abramson collaborates with scholars based in United States, Argentina and China. David H. Abramson's co-authors include Ira J. Dunkel, Jasmine H. Francis, Scott E. Brodie, Brian P. Marr, Y. Pierre Gobin, R. M. Ellsworth, Guillermo Chantada, Christopher M. Frank, Amy C Schefler and Robert M. Ellsworth and has published in prestigious journals such as Nature, Cell and JAMA.

In The Last Decade

David H. Abramson

376 papers receiving 11.5k citations

Hit Papers

align trajectories

Peers

Countries citing papers authored by David H. Abramson

Since Specialization

Citations

This map shows the geographic impact of David H. Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Abramson more than expected).

Fields of papers citing papers by David H. Abramson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Abramson. The network helps show where David H. Abramson may publish in the future.

Co-authorship network of co-authors of David H. Abramson

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Abramson. A scholar is included among the top collaborators of David H. Abramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Abramson. David H. Abramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy 2025 ·Radiation Oncology ·Hang Qi, (unknown), Sheng Huang, (unknown), Francis T. S. Yu, Qing Chen, Yunjie Yang, Minglei Kang, Huifang Zhai, M. A. Vermeulen, (unknown), Peter J. Park, Xuanfeng Ding, Jun Zhou, David H. Abramson, Jasmine H. Francis, (unknown), Christopher A. Barker, Haibo Lin	0
2	Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates 2024 ·Ophthalmology Retina ·Jasmine H. Francis, Anne S. Reiner, (unknown), David H. Abramson, Eli L. Diamond	0
3	The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations 2024 ·Clinical Cancer Research ·Josephine K. Dermawan, David H. Abramson, Sarah Chiang, Martee L. Hensley, William D. Tap, Sujana Movva, Robert G. Maki, Diana Mandelker, Cristina R. Antonescu	1
4	Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects 2023 ·Advances in Biological Regulation ·Abul Elahi, (unknown), Xiaoliang L. Xu, Alexia Eliades, Philippos C. Patsalis, David H. Abramson, Suresh C. Jhanwar	1
5	Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition? 2023 ·Ocular Oncology and Pathology ·Jasmine H. Francis, William Foulsham, (unknown), James J. Harding, Eli L. Diamond, David H. Abramson, Alexander Drilon	1
6	Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition 2022 ·American Journal of Ophthalmology Case Reports ·William Foulsham, (unknown), (unknown), Vicky Makker, Jason Konner, David H. Abramson, Jasmine H. Francis	4
7	Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression 2021 ·Nature Communications ·Mathieu F. Bakhoum, Jasmine H. Francis, Albert S. Agustinus, Ethan M. Earlie, Melody Di Bona, David H. Abramson, Mercedes A. Duran Paez, Ignas Masilionis, (unknown), Alexander N. Shoushtari, Michael H. Goldbaum, Paul S. Mischel, Samuel F. Bakhoum, Ashley M. Laughney	35
8	Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma 2021 ·SHILAP Revista de lepidopterología ·David H. Abramson, Diana Mandelker, Jasmine H. Francis, Ira J. Dunkel, A. Rose Brannon, Ryma Benayed, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Danielle Novetsky Friedman, Gowtham Jayakumaran, (unknown), (unknown), (unknown), Neerav Shukla, Michael F. Walsh, (unknown), Dana W.Y. Tsui	17
9	Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients 2021 ·Experimental Eye Research ·(unknown), Janene Pierce, (unknown), Yuankai K. Tao, Sheau‐Chiann Chen, Kelli L. Boyd, (unknown), (unknown), David H. Abramson, Jasmine H. Francis, Debra L. Friedman, Ann Richmond, Anthony B. Daniels	11
10	Benign Tumors in Long-Term Survivors of Retinoblastoma 2021 ·Cancers ·Milo van Hoefen Wijsard, Sara J. Schonfeld, Flora E. van Leeuwen, Annette C. Moll, Armida W. M. Fabius, David H. Abramson, Johanna M. Seddon, Jasmine H. Francis, Margaret A. Tucker, Ruth A. Kleinerman, Lindsay M. Morton	4
11	Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma 2020 ·PLoS ONE ·(unknown), (unknown), Jasmine H. Francis, Jessica A. Lavery, Audrey Mauguen, Scott E. Brodie, David H. Abramson	8
12	Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience 2020 ·Cancer Medicine ·(unknown), Francesco Marass, Julie L. Yang, Caitlin M. Stewart, Dennis Stephens, Juber Patel, Maysun Hasan, Xiaohong Jing, Fanli Meng, (unknown), Kety Huberman, Agnès Viale, Jasmine H. Francis, Michael F. Berger, Neerav Shukla, David H. Abramson, Ira J. Dunkel, Dana W.Y. Tsui	35
13	Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration 2019 ·International Journal of Molecular Sciences ·(unknown), (unknown), Federico Fuentes, (unknown), (unknown), (unknown), Claudia Sampor, David H. Abramson, Ángel M. Carcaboso, Paula Schaiquevich	18
14	Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma 2019 ·Ophthalmology Retina ·(unknown), Jasmine H. Francis, Sofia Haque, Ira J. Dunkel, Mark M. Souweidane, Danielle Novetsky Friedman, David H. Abramson	10
15	Fabrication of a custom brachytherapy appliance 2018 ·Journal of Prosthetic Dentistry ·(unknown), David H. Abramson, Suzanne L. Wolden, (unknown), Joseph Randazzo	2
16	Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma with Vitreous Seeding 2017 ·Europe PMC (PubMed Central) ·(unknown), Jasmine H. Francis, (unknown), Brian P. Marr, David H. Abramson	3
17	Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma 2014 ·Investigative Ophthalmology & Visual Science ·Anthony B. Daniels, Y. Pierre Gobin, Brian P. Marr, Jasmine H. Francis, Scott E. Brodie, David H. Abramson	1
18	Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma 2011 ·Clinical Cancer Research ·Mrinali Patel, Elizabeth Smyth, Paul B. Chapman, Jedd D. Wolchok, Gary K. Schwartz, David H. Abramson, Richard D. Carvajal	83
19	Salvage Chemosurgery for Resistant or Recurrent Retinoblastoma 2010 ·Investigative Ophthalmology & Visual Science ·(unknown), Y. Pierre Gobin, Brian P. Marr, Ira J. Dunkel, Scott E. Brodie, David H. Abramson	1
20	Treatment of Conjunctival Squamous Cell Carcinoma with Photodynamic Therapy - First Results 2003 ·Investigative Ophthalmology & Visual Science ·Irene Barbazetto, Thomas C Lee, (unknown), David H. Abramson	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact